Page results
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
UCLH consultant neurologist Dr Catherine Mummery has been announced as the new Chair of the NIHR Dementia Translational Research Collaboration.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
File results
-
FOI/2024/0132 - Cancer patients diagnosed in A&E
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)
-
FOI/2024/0134 - Joint infection services for paediatric/ adult patients
-
FOI/2024/0136 - Female Genital Mutilation (FGM) cases from 2014-February 2024
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer